טוען...
Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
Elderly patients with diabetes are at high risk of polypharmacy because of multiple coexisting diseases and syndromes. Polypharmacy increases the risk of drug–drug and drug–disease interactions in these patients, who may already have age-related sensory and cognitive deficits; such deficits may dela...
שמור ב:
| הוצא לאור ב: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628533/ https://ncbi.nlm.nih.gov/pubmed/31321014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319862691 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|